A Trial of Parent-coached Exposure Therapy for Children With Anxiety Disorders and OCD
NCT ID: NCT05777161
Last Updated: 2023-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
162 participants
INTERVENTIONAL
2020-11-11
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
NCT01194076
CBT for Pediatric OCD: Community Training Pilot
NCT02202915
Internet-based Cognitive-behavior Therapy for Children With Obsessive-compulsive Disorder
NCT02663167
Internet-delivered CBT for Paediatric OCD
NCT03263546
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
NCT07024758
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parent Coached Exposure Therapy-Individual (PCET-I) Group
Subjects will receive six to 14 weekly sessions of individual Parent Coached Exposure Therapy
Parent Coached Exposure Therapy - Individualized
Subject and parent begin by working with a therapist to create an individualized fear hierarchy consisting of situations and stimuli that produce anxiety for the child, gradually progressing from less anxiety to more anxiety.
Traditional Cognitive Behavior Therapy (CBT) Group
Subjects will receive 6 to 14 weekly sessions of individual Cognitive Behavioral Therapy
Cognitive Behavior Therapy
Subjects will work with a therapist using anxiety management strategies to address thoughts, feelings, and behaviors.
Parent Coached Exposure Therapy-5day Intensive (PCET-5day) Group (removed from study)
Subjects will receive 5 day (nine sessions) of group-based Parent Coached Exposure Therapy delivered within a span of five days (Monday through Friday), followed by 5 weeks of self-care
Parent Coached Exposure Therapy - Group (removed from study)
Subjects and parents will work in a group setting to receive exposure therapy consisting of situations and stimuli that produce anxiety for the child, gradually progressing from less anxiety to more anxiety.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parent Coached Exposure Therapy - Individualized
Subject and parent begin by working with a therapist to create an individualized fear hierarchy consisting of situations and stimuli that produce anxiety for the child, gradually progressing from less anxiety to more anxiety.
Cognitive Behavior Therapy
Subjects will work with a therapist using anxiety management strategies to address thoughts, feelings, and behaviors.
Parent Coached Exposure Therapy - Group (removed from study)
Subjects and parents will work in a group setting to receive exposure therapy consisting of situations and stimuli that produce anxiety for the child, gradually progressing from less anxiety to more anxiety.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be appropriate for the PADC standard outpatient therapy program, and be interested in starting outpatient therapy,
* Have the anxiety disorder as their primary diagnosis,
* If taking a selective serotonin reuptake inhibitor, SNRI, tricyclic, or antipsychotic medication, had no medication changes made at least 8 weeks prior to initiating participation in the study and agree to no changes during the 12 weeks of the study.
Exclusion Criteria
* Current positive diagnosis in the child's caregiver of mental retardation, psychosis, or other psychiatric disorders or conditions that would limit his/her ability to understand CBT and follow-through with treatment directives (based on clinical interview).
* Secondary diagnosis of oppositional defiant disorder or major depression of sufficient severity to prevent anxiety treatment.
* Severity of symptoms that warrant higher level of care (i.e. intensive, residential, IOP, inpatient)
* Family is unable to attend weekly sessions (i.e. geographical or scheduling barriers)
* History of good quality exposure or CBT.
7 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen Whiteside
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Whiteside, PhD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Minnesota
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-008982
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.